[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.17.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
January 13, 2010

Researchers Probe Targeted Agents’ Clinical Potential for Cancer Prevention

JAMA. 2010;303(2):115-116. doi:10.1001/jama.2009.1894

Boston—Favorable results from treatment trials have brought considerable attention to targeted cancer prevention. Meanwhile, research continues to identify proteins important for cancer development and progression, expanding the list of agents that might one day be suitable for healthy individuals at high risk of developing certain types of cancer.

Investigators discussed many of these agents and their targets at the recent Molecular Targets and Cancer Therapeutics International Conference, organized by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer.

First Page Preview View Large
First page PDF preview
First page PDF preview
×